Journal
HYPERTENSION IN PREGNANCY
Volume 34, Issue 1, Pages 102-115Publisher
TAYLOR & FRANCIS INC
DOI: 10.3109/10641955.2014.982331
Keywords
Decision-making; hospitalization; PlGF; preeclampsia; sFlt-1
Funding
- Roche Diagnostics
- Roche Diagnostics GmbH
- Roche Diagnostics GmbH, Sandhofer Strabetae Mannheim, Germany
Ask authors/readers for more resources
Objective: To assess how routine clinical use of the Roche fully automated Elecsys (R) sFlt-1/PlGF test changes decision-making of physicians to hospitalize pregnant women with suspected preeclampsia. Methods: The Preeclampsia Open Study (PreOS) study is a multicenter, prospective, open-label, non-interventional study in 150 women showing signs and symptoms of preeclampsia (suspected preeclampsia). Physicians record their intended procedures before and after knowledge of participants' sFlt-1/PlGF ratio. The study is conducted at five investigational sites in Germany and Austria. Conclusion: The PreOS study will provide evidence on how sFlt-1/PlGF ratio testing influences clinical decision-making in women with suspected preeclampsia in real-world clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available